๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition

โœ Scribed by C. Mahoney; B. Choudhury; H. Davies; G. Bignell; M. Stratton; A. Futreal

Book ID
119598529
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
97 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

9017 POSTER DISCUSSION Initial Detection
9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib
โœ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 43 KB
Correlation of expression of bombesin-li
Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines1The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Navy or the Department of Defense. This is a US Government work. There are no restrictions on its use.1
โœ Yang, Han-Kwang; Scott, Frank M; Trepel, Jane B; Battey, James F; Johnson, Bruce ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 362 KB